LUXEMBOURG & MELBOURNE, Australia--(BUSINESS WIRE)--Advanced Biological Laboratories S.A (ABL) today announced the acquisition of all the assets of Evivar Medical Pty Ltd (Evivar), which includes Evivar’s Hepatitis B virus (HBV) and C (HCV) web-based decision support tools for clinicians and the associated viral genome analysis systems (SeqHepB and SeqHepC), intellectual property portfolio, and all related commercial arrangements and operations.
